Tsujikawa T - Search Results

1

Increased oxidative stress is related to disease severity in the ALS motor cortex: A PET study.

Ikawa M, Okazawa H, Tsujikawa T, Matsunaga A, Yamamura O, Mori T, Hamano T, Kiyono Y, Nakamoto Y, Yoneda M. Ikawa M, et al. Among authors: tsujikawa t. Neurology. 2015 May 19;84(20):2033-9. doi: 10.1212/WNL.0000000000001588. Epub 2015 Apr 22. Neurology. 2015. PMID: 25904686

2

A 18F-FDG-positive, 67Ga-negative, and transferrin receptor expression-negative patient with diffuse large B-cell lymphoma.

Tsujikawa T, Okazawa H, Tsuchida T, Demura Y, Imamura Y, Fujibayashi Y. Tsujikawa T, et al. Ann Nucl Med. 2007 Aug;21(6):375-8. doi: 10.1007/s12149-007-0037-8. Epub 2007 Aug 27. Ann Nucl Med. 2007. PMID: 17705020

3

Shorter examination method for the diagnosis of misery perfusion with count-based oxygen extraction fraction elevation in 15O-Gas PET.

Kobayashi M, Kudo T, Tsujikawa T, Isozaki M, Arai Y, Fujibayashi Y, Okazawa H. Kobayashi M, et al. Among authors: tsujikawa t. J Nucl Med. 2008 Feb;49(2):242-6. doi: 10.2967/jnumed.107.047118. Epub 2008 Jan 16. J Nucl Med. 2008. PMID: 18199611 Free article.

4

Does partial volume corrected maximum SUV based on count recovery coefficient in 3D-PET/CT correlate with clinical aggressiveness of non-Hodgkin's lymphoma?

Tsujikawa T, Otsuka H, Morita N, Saegusa H, Kobayashi M, Okazawa H, Nishitani H. Tsujikawa T, et al. Ann Nucl Med. 2008 Jan;22(1):23-30. doi: 10.1007/s12149-007-0084-1. Ann Nucl Med. 2008. PMID: 18250984

5

Distinctive FDG and FES accumulation pattern of two tamoxifen-treated patients with endometrial hyperplasia.

Tsujikawa T, Okazawa H, Yoshida Y, Mori T, Kobayashi M, Tsuchida T, Fujibayashi Y. Tsujikawa T, et al. Ann Nucl Med. 2008 Jan;22(1):73-7. doi: 10.1007/s12149-007-0075-2. Ann Nucl Med. 2008. PMID: 18250990

6

Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET.

Tsuchida T, Takeuchi H, Okazawa H, Tsujikawa T, Fujibayashi Y. Tsuchida T, et al. Among authors: tsujikawa t. Nucl Med Biol. 2008 Feb;35(2):171-6. doi: 10.1016/j.nucmedbio.2007.11.004. Nucl Med Biol. 2008. PMID: 18312826 Clinical Trial.

7

Reproducibility of semi-quantitative parameters in FDG-PET using two different PET scanners: influence of attenuation correction method and examination interval.

Kamibayashi T, Tsuchida T, Demura Y, Tsujikawa T, Okazawa H, Kudoh T, Kimura H. Kamibayashi T, et al. Among authors: tsujikawa t. Mol Imaging Biol. 2008 May-Jun;10(3):162-6. doi: 10.1007/s11307-008-0132-9. Epub 2008 Apr 12. Mol Imaging Biol. 2008. PMID: 18408977 Free article.

8

Comparison of 18F-FDG PET and MRI in assessment of uterine smooth muscle tumors.

Yoshida Y, Kurokawa T, Sawamura Y, Shinagawa A, Tsujikawa T, Okazawa H, Tsuchida T, Imamura Y, Suganuma N, Kotsuji F. Yoshida Y, et al. Among authors: tsujikawa t. J Nucl Med. 2008 May;49(5):708-12. doi: 10.2967/jnumed.107.047142. Epub 2008 Apr 15. J Nucl Med. 2008. PMID: 18413400 Free article.

9

Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET--initial experience.

Tsujikawa T, Yoshida Y, Mori T, Kurokawa T, Fujibayashi Y, Kotsuji F, Okazawa H. Tsujikawa T, et al. Radiology. 2008 Aug;248(2):599-605. doi: 10.1148/radiol.2482071379. Epub 2008 Jun 6. Radiology. 2008. PMID: 18539894

10

Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images.

Tsujikawa T, Yoneda M, Shimizu Y, Uematsu H, Toyooka M, Ikawa M, Kudo T, Okazawa H, Kuriyama M, Kimura H. Tsujikawa T, et al. Brain Dev. 2010 Feb;32(2):143-9. doi: 10.1016/j.braindev.2008.12.003. Epub 2009 Jan 26. Brain Dev. 2010. PMID: 19171446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters